Grau SS - Search Results

1

SEOM clinical guideline for secondary prevention (2019).

Santaballa A, Pinto Á, Balanyà RP, Ramírez Merino N, Martín IR, Grau SS, Fombella JPB, Cano JM, González CH, Bayo J. Santaballa A, et al. Among authors: grau ss. Clin Transl Oncol. 2020 Feb;22(2):187-192. doi: 10.1007/s12094-020-02302-0. Epub 2020 Jan 31. Clin Transl Oncol. 2020. PMID: 32006339 Free article.

2

Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain.

Salavert M, Cobo J, Pascual Á, Aragón B, Maratia S, Jiang Y, Aceituno S, Grau S. Salavert M, et al. Adv Ther. 2018 Nov;35(11):1920-1934. doi: 10.1007/s12325-018-0813-y. Epub 2018 Oct 16. Adv Ther. 2018. PMID: 30328061 Free PMC article.

3

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer.

Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D. Isla D, et al. Clinicoecon Outcomes Res. 2016 Dec 30;9:31-38. doi: 10.2147/CEOR.S121093. eCollection 2017. Clinicoecon Outcomes Res. 2016. PMID: 28115857 Free PMC article.

4

SARS-CoV-2 could be spread through hospital medication dispensed to patients: A prospective observational study.

Grau S, Ferrández O, Echeverría-Esnal D, Maldonado R, Puig B, Ramirez A, Canal M, Montero A, González C, Herranz M, Masclans JR, Horcajada JP, Padilla E. Grau S, et al. Medicine (Baltimore). 2021 Nov 12;100(45):e27592. doi: 10.1097/MD.0000000000027592. Medicine (Baltimore). 2021. PMID: 34766561 Free PMC article.

5

Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospital.

Grau S, Conde-Estévez D, Luque S, Alvarez-Lerma F, Horcajada JP, Mateu-De Antonio J, Berenguer N, Salas E. Grau S, et al. J Chemother. 2010 Oct;22(5):339-44. doi: 10.1179/joc.2010.22.5.339. J Chemother. 2010. PMID: 21123158

6

Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.

Cámara R, Gozalbo I, Jurado M, Sanz J, Aragón B, Grau S. Cámara R, et al. Adv Ther. 2017 Sep;34(9):2104-2119. doi: 10.1007/s12325-017-0600-1. Epub 2017 Aug 14. Adv Ther. 2017. PMID: 28808915 Free PMC article.

7

Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Grau S, Cámara R, Jurado M, Sanz J, Aragón B, Gozalbo I. Grau S, et al. Eur J Health Econ. 2018 May;19(4):627-636. doi: 10.1007/s10198-017-0907-5. Epub 2017 May 31. Eur J Health Econ. 2018. PMID: 28569350

8

Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain.

Grau S, Salavert M, Carlos Pozo Laderas J, García Vargas M, Barrueta JA, Mir N. Grau S, et al. J Mycol Med. 2013 Sep;23(3):155-63. doi: 10.1016/j.mycmed.2013.05.004. Epub 2013 Jul 9. J Mycol Med. 2013. PMID: 23849341

9

[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document].

Rodríguez-Baño J, Paño-Pardo JR, Alvarez-Rocha L, Asensio A, Calbo E, Cercenado E, Cisneros JM, Cobo J, Delgado O, Garnacho-Montero J, Grau S, Horcajada JP, Hornero A, Murillas-Angoiti J, Oliver A, Padilla B, Pasquau J, Pujol M, Ruiz-Garbajosa P, San Juan R, Sierra R; Grupo de Estudio de la Infección Hospitalaria-Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica; Sociedad Española de Farmacia Hospitalaria; Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Rodríguez-Baño J, et al. Enferm Infecc Microbiol Clin. 2012 Jan;30(1):22.e1-22.e23. doi: 10.1016/j.eimc.2011.09.018. Epub 2011 Dec 15. Enferm Infecc Microbiol Clin. 2012. PMID: 22178010 Spanish.

10

EPICO 3.0. Management of non-neutropenic patients in medical wards.

Ferrer R, Zaragoza R, Rodríguez AH, Maseda E, Llinares P, Grau S, Álvarez-Lerma F, Quindós G, Salavert M, Huarte R; EPICO Project Group. Ferrer R, et al. Rev Iberoam Micol. 2016 Oct-Dec;33(4):216-223. doi: 10.1016/j.riam.2016.06.003. Epub 2016 Oct 18. Rev Iberoam Micol. 2016. PMID: 27769740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters